[HTML][HTML] Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials
…, T Le, YC Lin, WP Lin, TH Lin, MN Lyngbakken… - Nature …, 2021 - nature.com
Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs)
on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …
on hydroxychloroquine/chloroquine, which currently face recruitment challenges or …
[HTML][HTML] A pragmatic randomized controlled trial reports lack of efficacy of hydroxychloroquine on coronavirus disease 2019 viral kinetics
MN Lyngbakken, JE Berdal, A Eskesen, D Kvale… - Nature …, 2020 - nature.com
Here, we randomized 53 patients hospitalized with coronavirus disease 2019 (COVID-19) to
hydroxychloroquine therapy (at a dose of 400 mg twice daily for seven days) in addition to …
hydroxychloroquine therapy (at a dose of 400 mg twice daily for seven days) in addition to …
Novel biomarkers of cardiovascular disease: applications in clinical practice
MN Lyngbakken, PL Myhre, H Røsjø… - Critical reviews in …, 2019 - Taylor & Francis
Measurement of biomarkers has revolutionized the work-up of patients with suspected
cardiovascular disease. The most widely used contemporary cardiovascular biomarkers are the …
cardiovascular disease. The most widely used contemporary cardiovascular biomarkers are the …
Prevalence of carotid plaque in a 63‐to 65‐Year‐old Norwegian cohort from the general population: the ACE (Akershus Cardiac Examination) 1950 study
…, B Thommessen, MN Lyngbakken… - Journal of the …, 2018 - Am Heart Assoc
Background New data on extracranial carotid atherosclerosis are needed, as improved
ultrasound techniques may detect more atherosclerosis, the definition of plaque has changed …
ultrasound techniques may detect more atherosclerosis, the definition of plaque has changed …
Prevalence of atrial fibrillation and cardiovascular risk factors in a 63–65 years old general population cohort: the Akershus Cardiac Examination (ACE) 1950 Study
T Berge, MN Lyngbakken, H Ihle-Hansen… - BMJ open, 2018 - bmjopen.bmj.com
Objectives To investigate the sex-specific prevalence of atrial fibrillation (AF), including
subclinical AF found by screening in a general population aged 63–65 years. The prevalence of …
subclinical AF found by screening in a general population aged 63–65 years. The prevalence of …
Impact of smoking on circulating cardiac troponin I concentrations and cardiovascular events in the general population: the HUNT Study (Nord-Trøndelag Health Study …
MN Lyngbakken, JB Skranes, JA de Lemos, S Nygård… - Circulation, 2016 - Am Heart Assoc
Background: Both tobacco smoking and circulating cardiac troponin I (cTnI) levels are
associated with the risk of acute myocardial infarction, heart failure, and cardiovascular death. …
associated with the risk of acute myocardial infarction, heart failure, and cardiovascular death. …
Gender, high-sensitivity troponin I, and the risk of cardiovascular events (from the Nord-Trøndelag Health Study)
Gender is an important determinant of cardiovascular risk, and men generally develop
cardiovascular disease earlier than women. Increased levels of high-sensitivity cardiac troponin I (…
cardiovascular disease earlier than women. Increased levels of high-sensitivity cardiac troponin I (…
Cardiac troponin I and T are associated with left ventricular function and structure: data from the akershus cardiac examination 1950 study
MN Lyngbakken, EN Aagaard, B Kvisvik… - Clinical …, 2020 - academic.oup.com
Background Concentrations of cardiac troponin I (cTnI) and T (cTnT) are associated with
clinical cardiac outcomes, but do not correlate closely in subjects recruited from the general …
clinical cardiac outcomes, but do not correlate closely in subjects recruited from the general …
Heart and brain interactions–the Akershus Cardiac Examination (ACE) 1950 study design
…, H Ihle-Hansen, MN Lyngbakken… - Scandinavian …, 2015 - Taylor & Francis
Objectives. The aim of the Akershus Cardiac Examination (ACE) 1950 Study is to investigate
the development and progression of cardiovascular and cerebrovascular disease (CVD/…
the development and progression of cardiovascular and cerebrovascular disease (CVD/…
Mortality and length of hospital stay after bloodstream infections caused by ESBL-producing compared to non-ESBL-producing E. coli
N Handal, J Whitworth, MN Lyngbakken… - Infectious …, 2024 - Taylor & Francis
Objective To compare mortality and length of hospital stay between patients with ESBL-producing
E. coli bloodstream infections (BSIs) and patients with non-ESBL E. coli BSIs. We also …
E. coli bloodstream infections (BSIs) and patients with non-ESBL E. coli BSIs. We also …